New drug combo could ease painful mouth condition
NCT ID NCT07131813
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests whether adding the drug tofacitinib to standard steroid treatment helps people with oral lichen planus, a chronic inflammatory mouth condition. About 60 adults with moderate to severe symptoms will receive either tofacitinib or a placebo alongside their usual steroid ointment for 12 weeks. The goal is to see if the combination reduces disease severity and pain better than steroids alone, while potentially lowering steroid side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL LICHEN PLANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AIIMS, Bhubaneswar
RECRUITINGBhubaneswar, Odisha, 751019, India
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.